Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO
April 4, 2024
Transit Scientific is excited to announce that Jennifer Arnold, current COO of Transit Scientific has been promoted to President & CEO of Transit Scientific effective immediately.
Jennifer has been with Transit Scientific for 5+ years, serving in various roles including Vice President of Engineering and Chief Operating Officer. She brings a wealth of knowledge to the role with experience in engineering, regulatory, and supply chain. Jennifer has overseen 7 FDA and 2 CE Mark submissions covering 130+ unique device SKUs with a 100% approval rate to date, currently has 1 patent allowed and 6 patents pending, and was awarded Utah Business’s 40 under 40 business leaders in 2024.
Jennifer comments, “As I transition from Chief Operating Officer to President and CEO, I am deeply honored and excited to take on this new role. With inspired dedication, I look forward to steering Transit Scientific toward continued growth and innovation. Together with our talented team, we will uphold our commitment to advancing healthcare solutions and improving patient outcomes.”
Recent News
- Improving Women’s Health: MobileODT Joins Liger Medical
- Wasatch Health Announces Structured Capital Fund
- Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
- Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
- Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)